Chart looks good, very good. Was this chart from a previous study however? Where the virus is tested externally in a laboratory setting vs this IV one?
If this is the chart post IV, then it's off to the races.
Regardless, its proven to work significantly well and more rapidly than all its peer competing antibiotics to date, as stipulated. And given its proven to be working in the tract in this trial, then one would think it must remain the superior drug throughout the process.
Ann: Phase I/II UTI/Urosepsis Rapid Infusion Trial Complete, page-19
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.005(1.67%) |
Mkt cap ! $85.06M | |||
| Open | High | Low | Value | Volume |
| 29.5¢ | 29.5¢ | 29.0¢ | $38.76K | 133.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 135000 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 9819 | 2 |
View Market Depth
| Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |